EFFECT OF DEFEROXAMINE MESYLATE ON THE GROWTH OF MUCORALES

被引：10
|
作者：
NIIMI, O
KOKAN, A
KASHIWAGI, N
机构：
[1] CIBA GEIGY JAPAN,DEPT DRUG INFORMAT,10-66 MIYUKI CHO,TAKARAZUKA,HYOGO 665,JAPAN
[2] HIROSHIMA UNIV,FAC ENGN,HIROSHIMA 730,JAPAN
来源：
NEPHRON | 1989年 / 53卷 / 03期
关键词：
D O I：
10.1159/000185761
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：281 / 282
页数：2
相关论文
共 50 条
  • [31] DEFEROXAMINE AUGMENTS GROWTH AND PATHOGENICITY OF RHIZOPUS, WHILE HYDROXYPYRIDINONE CHELATORS HAVE NO EFFECT
    BOELAERT, JR
    VANCUTSEM, J
    DELOCHT, M
    SCHNEIDER, YJ
    CRICHTON, RR
    KIDNEY INTERNATIONAL, 1994, 45 (03) : 667 - 671
  • [32] Intranasal deferoxamine mesylate alleviates silica-induced pulmonary fibrosis by regulating iron homeostasis
    Tian, L.
    Zhu, Z.
    Huang, P.
    TOXICOLOGY LETTERS, 2024, 399 : S341 - S341
  • [33] ACCELERATED REMOVAL OF DEFEROXAMINE MESYLATE-CHELATED ALUMINUM BY CHARCOAL HEMOPERFUSION IN HEMODIALYSIS-PATIENTS
    DELMEZ, J
    WEERTS, C
    LEWISFINCH, J
    WINDUS, D
    SLATOPOLSKY, E
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1989, 13 (04) : 308 - 311
  • [34] THE EFFECT OF DEFEROXAMINE ON DIFFERENT ZYGOMYCETES
    BOELAERT, JR
    DELOCHT, M
    SCHNEIDER, YJ
    JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (01): : 231 - 232
  • [35] DEFEROXAMINE MESYLATE ENHANCEMENT OF GA-67 TUMOR-TO-BLOOD RATIOS AND TUMOR IMAGING
    KOIZUMI, K
    TONAMI, N
    HISADA, K
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1982, 7 (05): : 229 - 233
  • [36] Effect of deferoxamine on the rod photoresponse
    Lu, M
    Hansen, R
    Fulton, R
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U433 - U433
  • [37] Treatment with the Iron Chelator, Deferoxamine Mesylate, Alters Serum Markers of Oxidative Stress in Stroke Patients
    Magdy Selim
    Translational Stroke Research, 2010, 1 : 35 - 39
  • [38] FAILURE OF DEFEROXAMINE MESYLATE TO PROTECT AGAINST CERULETIDE-INDUCED ACUTE-PANCREATITIS IN RATS
    WISNER, JR
    GREEN, DW
    RENNER, IG
    GASTROENTEROLOGY, 1986, 90 (05) : 1694 - 1694
  • [39] Treatment with the Iron Chelator, Deferoxamine Mesylate, Alters Serum Markers of Oxidative Stress in Stroke Patients
    Selim, Magdy
    TRANSLATIONAL STROKE RESEARCH, 2010, 1 (01) : 35 - 39
  • [40] Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression
    Beppu, K
    Jaboine, J
    Merchant, MS
    Mackall, CL
    Thiele, CJ
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (01): : 46 - 55
12345